Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that completed its public market debut in February 2021 through a merger with Longboard Acquisition Corp., a blank-check vehicle sponsored by Longboard Capital Advisors. The company develops handheld, whole-body ultrasound devices built on a proprietary semiconductor chip platform, targeting both clinical and point-of-care settings across the digital health sector. Trading on the New York Stock Exchange since the deal closed, Butterfly Network filed its most recent 8-K on June 22, 2026, reflecting its ongoing disclosure obligations as a post-merger public company. Visit SpacDesk and sign up for full filing history, deal analytics, and real-time data on BFLY and hundreds of other SPAC transactions.